BOT 8.70% 31.5¢ botanix pharmaceuticals ltd

Ann: December 2023 Quarterly Activities Report and Appendix 4C, page-6

  1. 3,224 Posts.
    lightbulb Created with Sketch. 774
    From $302,000 to $497,000 - That's an increase of 164.57%

    Lets imagine for a second that $500,000.00 a quarter in monies from Kaken is going to be the norm, that's $2,000,000.00 a year. Let pretend for a moment this does not increase beyond here (likely it will continue to increase but let's pretend) - add Korea into the mix at the same levels - That's over $4,000,000.00 a year in just territory deals...

    This is going to be at minimum!!!
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.